Location History:
- Yongin-si, KR (2014)
- Gyeonggi-do, KR (2016)
Company Filing History:
Years Active: 2014-2016
Title: Yong Ha Chi: Innovator in Pharmaceutical Development
Introduction
Yong Ha Chi is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with angiogenesis inhibitory activity and antihypertensive properties. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Yong Ha Chi's latest patents include a compound having angiogenesis inhibitory activity and an antihypertensive pharmaceutical composition. The first patent discloses an anti-angiogenic compound, represented by Chemical Formula I, which potently suppresses angiogenesis. This compound is applicable for the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, making it a valuable anti-angiogenic agent. The second patent provides an antihypertensive pharmaceutical composition that contains Fimasartan, an angiotensin II receptor blocker, and Amlodipine, a calcium channel blocker. These innovations are crucial for developing effective treatments for hypertension.
Career Highlights
Yong Ha Chi is currently associated with Boryung Pharmaceutical Co., Ltd., where he continues to contribute to pharmaceutical research and development. His expertise in creating innovative compounds has positioned him as a key player in the industry.
Collaborations
Yong Ha Chi has collaborated with notable colleagues, including Ji Han Kim and Je Hak Kim. Their combined efforts in research and development have led to significant advancements in pharmaceutical formulations.
Conclusion
Yong Ha Chi's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to inspire advancements in the industry, making a lasting impact on healthcare.